New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Emory University
Mayo Clinic
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
AstraZeneca
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fudan University
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Children's Oncology Group
Ohio State University Comprehensive Cancer Center
Canadian Cancer Trials Group
Mayo Clinic
BPGbio
NRG Oncology
NRG Oncology
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Karolinska Institutet
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Nebraska
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Sheba Medical Center
Massachusetts General Hospital
Goethe University
Massachusetts General Hospital